Celldex Therapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Celldex Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q4 2024.
  • Celldex Therapeutics, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$56M, a 17.6% decline year-over-year.
  • Celldex Therapeutics, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$195M, a 26.2% decline year-over-year.
  • Celldex Therapeutics, Inc. annual Operating Income (Loss) for 2024 was -$195M, a 26.2% decline from 2023.
  • Celldex Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$155M, a 34.1% decline from 2022.
  • Celldex Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$115M, a 61.7% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$195M -$56M -$8.4M -17.6% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-27
Q3 2024 -$187M -$52.1M -$10.9M -26.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 -$176M -$46.3M -$13.1M -39.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$163M -$40.6M -$8.14M -25.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 -$155M -$47.6M -$19.7M -70.8% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-27
Q3 2023 -$135M -$41.2M -$13.5M -48.9% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 -$121M -$33.2M +$3.19M +8.77% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$124M -$32.5M -$9.21M -39.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 -$115M -$27.9M -$7.55M -37.1% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-27
Q3 2022 -$108M -$27.7M -$6.87M -33% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 -$101M -$36.4M -$23M -171% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$77.9M -$23.3M -$6.62M -39.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$71.2M -$20.3M +$4.44M +17.9% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 -$75.7M -$20.8M -$6.48M -45.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$69.2M -$13.4M -$2.08M -18.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$67.1M -$16.6M -$3.77M -29.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$63.4M -$24.8M -$11.8M -90.8% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 -$51.6M -$14.3M -$2.5M -21.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$49.1M -$11.4M +$892K +7.28% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$50M -$12.9M +$5.07M +28.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$55M -$13M -$867K -7.15% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 -$54.2M -$11.8M -$4.08M -52.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$50.1M -$12.3M +$4.62M +27.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$54.7M -$17.9M +$102M +85% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 -$156M -$12.1M +$13.4M +52.5% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-29
Q3 2018 -$170M -$7.76M +$24.2M +75.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$194M -$16.9M +$12.1M +41.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 -$206M -$120M -$84.6M -241% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 -$122M -$25.5M +$9.33M +26.8% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-26
Q3 2017 -$131M -$32M -$1.97M -6.56% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 -$129M -$28.9M +$3.44M +10.6% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 -$132M -$35.1M +$592K +1.66% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$133M -$34.9M -$1.41M -4.23% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-07
Q3 2016 -$132M -$30M +$2.38M +7.35% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 -$134M -$32.4M +$384K +1.17% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 -$134M -$35.7M -$4.72M -15.2% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 -$130M -$33.4M -$1.39M -4.33% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-07
Q3 2015 -$128M -$32.4M -$2.03M -6.69% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 -$126M -$32.8M -$4.2M -14.7% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 -$122M -$31M +$508K +1.61% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-05
Q4 2014 -$122M -$32.1M -$9.94M -44.9% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-14
Q3 2014 -$112M -$30.3M -$7.07M -30.4% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-05
Q2 2014 -$105M -$28.5M -$9.89M -53% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$95.5M -$31.5M -$14.1M -81% Jan 1, 2014 Mar 31, 2014 10-Q 2015-04-29
Q4 2013 -$81.4M -$22.1M -$5.56M -33.6% Oct 1, 2013 Dec 31, 2013 10-K/A 2016-02-25
Q3 2013 -$75.9M -$23.3M -$8.52M -57.7% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-05
Q2 2013 -$67.4M -$18.7M -$5.17M -38.3% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 -$62.2M -$17.4M -$4.11M -31% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-01
Q4 2012 -$58.1M -$16.6M -$4.17M -33.7% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-24
Q3 2012 -$53.9M -$14.8M -$3.27M -28.5% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-08
Q2 2012 -$50.6M -$13.5M -$3.61M -36.5% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q1 2012 -$47M -$13.3M -$3.63M -37.6% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-03
Q4 2011 -$43.4M -$12.4M Oct 1, 2011 Dec 31, 2011 10-K 2014-03-03
Q3 2011 -$11.5M -$2.6M -29.3% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-02
Q2 2011 -$9.88M -$595K -6.41% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 -$9.66M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-04
Q3 2010 -$8.88M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-03
Q2 2010 -$9.29M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.